Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
- PMID:30120413
- PMCID: PMC6378141
- DOI: 10.1038/s41380-018-0212-4
Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation
Abstract
The dopamine (DA) D2 receptor (D2R) is an important target for the treatment of neuropsychiatric disorders such as schizophrenia and Parkinson's disease. However, the development of improved therapeutic strategies has been hampered by our incomplete understanding of this receptor's downstream signaling processes in vivo and how these relate to the desired and undesired effects of drugs. D2R is a G protein-coupled receptor (GPCR) that activates G protein-dependent as well as non-canonical arrestin-dependent signaling pathways. Whether these effector pathways act alone or in concert to facilitate specific D2R-dependent behaviors is unclear. Here, we report on the development of a D2R mutant that recruits arrestin but is devoid of G protein activity. When expressed virally in "indirect pathway" medium spiny neurons (iMSNs) in the ventral striatum of D2R knockout mice, this mutant restored basal locomotor activity and cocaine-induced locomotor activity in a manner indistinguishable from wild-type D2R, indicating that arrestin recruitment can drive locomotion in the absence of D2R-mediated G protein signaling. In contrast, incentive motivation was enhanced only by wild-type D2R, signifying a dissociation in the mechanisms that underlie distinct D2R-dependent behaviors, and opening the door to more targeted therapeutics.
Conflict of interest statement
Conflict of Interest
The authors declare no conflicts of interest.
Figures





Similar articles
- Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.Peterson SM, Pack TF, Wilkins AD, Urs NM, Urban DJ, Bass CE, Lichtarge O, Caron MG.Peterson SM, et al.Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7097-102. doi: 10.1073/pnas.1502742112. Epub 2015 May 11.Proc Natl Acad Sci U S A. 2015.PMID:25964346Free PMC article.
- Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.Rose SJ, Pack TF, Peterson SM, Payne K, Borrelli E, Caron MG.Rose SJ, et al.Neuropsychopharmacology. 2018 Apr;43(5):1164-1173. doi: 10.1038/npp.2017.254. Epub 2017 Oct 25.Neuropsychopharmacology. 2018.PMID:29068002Free PMC article.
- Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.Liu H, Ma H, Zeng X, Wu C, Acharya S, Sudan SK, Zhang X.Liu H, et al.Int J Mol Sci. 2023 Jun 12;24(12):10031. doi: 10.3390/ijms241210031.Int J Mol Sci. 2023.PMID:37373182Free PMC article.
- Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders.Dobbs LK, Lemos JC, Alvarez VA.Dobbs LK, et al.Genes Brain Behav. 2017 Jan;16(1):56-70. doi: 10.1111/gbb.12361.Genes Brain Behav. 2017.PMID:27860248Free PMC article.Review.
- Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.Prasad K, de Vries EFJ, Elsinga PH, Dierckx RAJO, van Waarde A.Prasad K, et al.Int J Mol Sci. 2021 Feb 9;22(4):1719. doi: 10.3390/ijms22041719.Int J Mol Sci. 2021.PMID:33572077Free PMC article.Review.
Cited by
- Dopamine and Dopamine Receptors in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.Pan X, Kaminga AC, Wen SW, Wu X, Acheampong K, Liu A.Pan X, et al.Front Aging Neurosci. 2019 Jul 11;11:175. doi: 10.3389/fnagi.2019.00175. eCollection 2019.Front Aging Neurosci. 2019.PMID:31354471Free PMC article.
- Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids.Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D.Porter-Stransky KA, et al.Addict Biol. 2020 Nov;25(6):e12823. doi: 10.1111/adb.12823. Epub 2019 Aug 23.Addict Biol. 2020.PMID:31441201Free PMC article.
- OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz.Keen AC, Pedersen MH, Lemel L, Scott DJ, Canals M, Littler DR, Beddoe T, Ono Y, Shi L, Inoue A, Javitch JA, Lane JR.Keen AC, et al.Commun Biol. 2022 Mar 23;5(1):256. doi: 10.1038/s42003-022-03191-5.Commun Biol. 2022.PMID:35322196Free PMC article.
- Inhibition of Colony-Stimulating Factor 1 Receptor by PLX3397 Prevents Amyloid Beta Pathology and Rescues Dopaminergic Signaling in Aging 5xFAD Mice.Son Y, Jeong YJ, Shin NR, Oh SJ, Nam KR, Choi HD, Choi JY, Lee HJ.Son Y, et al.Int J Mol Sci. 2020 Aug 3;21(15):5553. doi: 10.3390/ijms21155553.Int J Mol Sci. 2020.PMID:32756440Free PMC article.
- The histamine H3 receptor modulates dopamine D2 receptor-dependent signaling pathways and mouse behaviors.Xu J, Pittenger C.Xu J, et al.J Biol Chem. 2023 Apr;299(4):104583. doi: 10.1016/j.jbc.2023.104583. Epub 2023 Mar 4.J Biol Chem. 2023.PMID:36871761Free PMC article.
References
- Beninger RJ. The role of dopamine in locomotor activity and learning. Brain research 1983; 287(2): 173–196. - PubMed
- Wise RA. Dopamine, learning and motivation. Nature reviews Neuroscience 2004; 5(6): 483–494. - PubMed
- Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205(4409): 929–932. - PubMed
- Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron 2003; 39(6): 889–909. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases